|
ZNF551 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.53089999996603E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91292999999204E-05 |
| Normal-vs-Stage2 |
3.602300E-04 |
| Normal-vs-Stage3 |
1.54024999999836E-05 |
| Normal-vs-Stage4 |
3.85370000022256E-07 |
| Stage1-vs-Stage2 |
7.756600E-01 |
| Stage1-vs-Stage3 |
2.683600E-01 |
| Stage1-vs-Stage4 |
2.999700E-03 |
| Stage2-vs-Stage3 |
4.679800E-01 |
| Stage2-vs-Stage4 |
5.427700E-02 |
| Stage3-vs-Stage4 |
2.102400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7654699999925E-05 |
| Normal-vs-AfricanAmerican |
1.809310E-04 |
| Normal-vs-Asian |
9.760300E-04 |
| Caucasian-vs-AfricanAmerican |
9.973000E-01 |
| Caucasian-vs-Asian |
1.128580E-01 |
| AfricanAmerican-vs-Asian |
3.920400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74279999992844E-07 |
| Normal-vs-Female |
5.195500E-02 |
| Male-vs-Female |
2.904200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.568000E-04 |
| Normal-vs-Extreme_Weight |
8.89750000010459E-07 |
| Normal-vs-Obese |
1.842910E-03 |
| Normal-vs-Extreme_Obese |
4.784700E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.054600E-01 |
| Normal_Weight-vs-Obese |
4.102000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.757800E-01 |
| Extreme_Weight-vs-Obese |
9.482400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.716200E-01 |
| Obese-vs-Extreme_Obese |
2.826600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.716400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.881150E-03 |
| Normal-vs-Age(61-80Yrs) |
6.64879999945356E-07 |
| Normal-vs-Age(81-100Yrs) |
9.61110000030629E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.350800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.825000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.141590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.022300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.121800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.166200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.94270000000363E-05 |
| Normal-VS-Type2 PRCC |
4.64960003832005E-09 |
| Normal-VS-KIRP CIMP |
9.096500E-02 |
| Normal-VS-Unclassified PRCC |
1.863590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.432000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.342200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.007750E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.248800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.120900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.692000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73069999997999E-07 |
| Normal-vs-N1 |
6.380200E-03 |
| Normal-vs-N2 |
2.222800E-04 |
| N0-vs-N1 |
2.606600E-01 |
| N0-vs-N2 |
2.344400E-01 |
| N1-vs-N2 |
1.762050E-01 |
|
|
